We are live on ! Find out more

Mid Cap Healthcare
Stocks Ranked by
Market Capitalization

Mid Cap Healthcare Stocks at a Glance

Healthcare companies develop drugs, build medical devices, run hospitals and insurers, and supply the systems behind patient care. Demand is largely non-discretionary, but returns hinge on drug-pipeline outcomes, patent lives, and reimbursement policy — a mix of defensive services and high-risk, high-reward research bets.

There are 148 mid cap Healthcare stocks — companies in the Healthcare sector with a market cap between $2B and $10B — worth a combined $679B.

The largest by market cap are Bio-Rad Laboratories Class A (BIO) at $9.9B, Vaxcyte (PCVX) at $9.7B and Henry Schein (HSIC) at $9.5B.

Among institutional investors, Trulieve Cannabis Corp (TRLV) drew the most net new fund positions in Q2 2026: 123 funds opened new positions, taking total fund holders up 121 (2,017%) quarter-over-quarter.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.